Biokemijska istraživanja i ekspresija akvaporina 9 (AQP9) u divljih miševa i miševa s odstranjenim genom za AQP9 by Mohamed A. Hashem
93ISSN 0372-5480Printed in Croatia
VETERINARSKI ARHIV 80 (1), 93-112, 2010
Biochemical and expression studies on Aquaporin 9 (AQP9) in wild 
and AQP9 knockout mice
Mohamed A. Hashem
Department of Clinical Pathology, Faculty of Veterinary Medicine, Zagazig University, Egypt
HASHEM, M. A.: Biochemical and expression studies on Aquaporin 9 (AQP9) in 
wild and AQP9 knockout mice. Vet. arhiv 80, 93-112, 2010.
ABSTRACT
The objective of this study was to determine the cellular and subcellular localization of AQP9 in 
different organs of wild-type (AQP9+/+ ) and AQP9 knockout mice (AQP9-/- ) by immunohistochemistry (IHC), 
immunofl uorescence (IF) and RT-PCR, as well as some biochemical evaluation. Twenty wild and homozygous 
AQP9 KO-mice (C57 BL/6J) were used. Both AQP9+/+ and AQP9-/- were randomly assigned to 4 subgroups 
based on sex type. IHC analyses revealed AQP9 specifi c labeling in the hepatocytes, kidney, spleen and epididymis 
of wild type mice (AQP9+/+ ), but a complete absence of labeling in AQP9-/- mice. In the liver, labeling was strongest 
at the sinusoidal surface, and there was little intracellular labeling. AQP9 expression was found to be sex-linked. 
In the liver of females, the expression of AQP9 was mostly confi ned to perivascular hepatocytes, whereas males 
showed more homogeneous hepatocyte staining. Confocal immunofl uorescence confi rmed the localization of AQP9 
immunostaining on the basolateral plasma membrane of hepatocytes. Compared with the control mice, serum levels 
of glycerol and triglycerides were signifi cantly (P<0.05) increased, in association with hypoglycemia in the AQP9-
/- mice, whereas the total cholesterol, urea, alanine aminotransferase, and alkaline phosphatase were not statistically 
different. 
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Introduction
Aquaporins (AQPs) are members of a large family of integral membrane proteins 
involved in the rapid movement of water and neutral solutes across cell membranes 
(CAPERNA et al., 2007; KRANE and GOLDSTEIN, 2007) and are fundamentally important 
to fl uid transport in the bile ducts and ductules of the liver (TALBOT et al., 2003). Various 
disease states have been associated with alterations in AQP expression and targeting in 
cells (VAN OS et al., 2000). 
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To date, 12 isoforms of AQPs (AQP0-AQP12) have been identifi ed in a wide variety 
of mammal cells (HUANG et al., 2006; ISHIBASHI et al., 2002; MARINELLI et al., 2004) and 
have greatly infl uenced the medical sciences (MAEDA et al., 2008). Among 13 identifi ed 
mammalian aquaporins, AQP3, AQP7, AQP9, and AQP10 represent the aquaglyceroporin 
subfamily, on the basis of their amino acid sequences and solute permeabilities (AGRE et 
al., 2002). In the liver, AQP9 is expressed in hepatocytes within the sinusoidal surfaces of 
hepatocyte plates, where, during starvation, it is speculated to function in glycerol uptake 
from the bloodstream for gluconeogenesis (CARBREY et al., 2003; GRADILONE et al., 2005; 
KURIYAMA et al., 2002). In addition, it has been proposed that AQP9 is involved in urea 
elimination from hepatocytes (ISHIBASHI et al., 1998). AQP9 expression has been reported 
in other tissues, including the male reproductive tract, where it localizes to the efferent 
ductule epithelium, epididymis, and vas deferens of rats (PASTOR-SOLER et al., 2002). It 
is important to emphasize that, despite an abundance of data from different studies; there 
are still major discrepancies between the reported expression sites. In speculation, these 
differences may be due to either heterogeneity of expression in different species, or the 
existence of different splice variants, or may represent artifacts related to specifi city of the 
anti-AQP9 antibodies used in immunohistochemistry (IHC), immunofl uorescence (IF) 
and immunoblotting methods. 
The aims of the present study were: 1) to identify the exact tissue localization of 
AQP9 in mice, males or females, wild-type and/or knockout- type, 2) to study some 
biochemical analyses in wild and knockout mice, 3) to study the liver structure of wild 
and knockout mice by electron microscopy.
Materials and methods
AQP9 knockout mice. The generation of AQP9 knockout (KO) mice was accomplished 
by completely removal of whole exon5 from AQP9 genomic DNA and substituted for 
nucleotides sequence encoding a neomycin phosphotransferase expression cassette (Fig. 
1). This was done in the Structural Pathology Department, Institute of Nephrology, Niigata 
University, Japan. For AQP9 genotyping, the mice were tested by PCR using genomic tail 
DNA and 2 primers set.
Experimental animals. A total of 10 wild type and 10 homozygous AQP9 KO-mice (C57 
BL /6J), 2-3 months of age, were used. Both AQP9+/+ and AQP9-/- were randomly assigned 
to 4 subgroups based on sex type. All mice were housed at a controlled temperature, 
had free access to food and water and were maintained on 12-hourr light-dark cycles. 
Experiments involving these mice were approved by the Animal Care Committees of 
Niigata School of Medical and Dental Sciences. 
Antibodies. An affi nity-purifi ed rabbit polyclonal antibody against an AQP9 C-terminal 
peptide from rat AQP9 (DAKO, Carpentaria, CA, USA) was used as a primary antibody. 
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The antibody was diluted 1:100 with sterile phosphate buffer saline (PBS) containing 0.05% 
sodium azide (NaN3) before use. A horseradish-peroxidase (HRP) conjugated to goat anti-
rabbit immunoglobulins (EnVision, DAKO, Kyoto, Japan) was used as a secondary antibody 
in dilution 1:5 with sterile PBS containing 0.02% NaN3 for immunohistochemistry (IHC). 
For immunofl uorescence (IF), fl uorescein isothiocyanate (FITC) - labeled goat anti-rabbit 
polyclonal IgG from IBL (Immuno-Biological Laboratories, Takasaki, Gunma, Japan) in 
dilution 1:100 with sterile PBS containing 0.05% NaN3 was used as a secondary antibody.
Primers. The primer sets were obtained from Nihon Gene Res. Lab., Miyagi, Sendai 
city, Japan. 
For AQP9 genotyping, 2 primers were used: 5’-CAAATCCCAGCAACCATCTG-3’ 
and 5’-GTAGCACATGCTTGCAATGC-3’. The expected PCR product for homozygous 
AQP9 KO- mice is 350 bp, for wild-type mice is 605 bp and both for heterozygous mice 
(AQP9+/-). 
To amplify specifi cally AQP9 transcript, 2 primers were designed from 
the sequence of full-length cDNA (GenBank accession no. 022026): A sense 
primer: 5’-CTCATCACGGGAGAAAATGG-3’ and an antisense primer: 5’-
GCTGGTTCTGCCTTCACTTC-3’ (the expected PCR product is 437bp). For a positive 
control, glyceraldehydes 3-phosphate dehydrogenase (GAPDH) was used as a house-keeping 
gene. The sense primer was 5’-CAAGATGGTGAAGGTCGGTG-3’ and the antisense primer 
5’-GAAGATGGTGATGGGTTTCC-3’(PCR product is 239bp).
Serum analysis. Blood was drawn from the supra-orbital venous plexus of AQP9+/+ and 
AQP9-/- mice under light ether anesthesia, left for clotting, and clear sera were separated 
after centrifugation at 2000 ×g for 20 min at 4 °C for blood chemistry using diagnostic 
kits (Biomeria /France). Serum glycerol and triglycerides were determined according to 
the method of HERCULES and SHEEHAN (1978). Serum total cholesterol (RICHMOND, 
1973), glucose using glucose oxidase method (TRINDER, 1969) and urea (ORSONNEAU et al., 
1992) were estimated. The serum activities of alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST) were determined colorimetrically according to REITMAN and 
FRANKEL (1957). 
Immunohistochemistry (IHC). Immunoperoxidase staining was carried out according 
to the procedure of KOYAMA et al. (1999). The tissues (liver, kidney, spleen, pancreas, 
stomach, intestine, heart, lung, skin, brain, testis, epididymis, uterus and ovary) from wild 
type and AQP9-/- mice were fi xed with methyl-Carnoy’s fi xative (60% methanol, 30% 
chloroform, 10% acetic acid), embedded in paraffi n, and sectioned at 4 μm thickness. 
Sections were incubated overnight at 4 °C with primary rabbit anti-rat AQP9 antibody (2 
μg/mL). After being washed (PBS for 3 × 5 min), slides were incubated for 1 hour at room 
temperature with secondary antibody, HRP-coupled goat anti-rabbit immunoglobulins 
(EnVision), and washed again as described above. The peroxidase reaction was developed 
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with 0.05% 3, 3′-diaminobenzidine tetrahydrochloride (DAB) and counterstained with 
Mayer’s hematoxylin for 3 min. The immunostained sections were dehydrated in ethanol 
series and mounted with mounting medium. Then the immunocytochemical signal was 
examined with an Eclipse E800 light microscope (Nikon, Niigata, Japan). For the control, 
sections were incubated without primary antibody and showed no staining. 
Immunofl uorescence (IF). Liver tissues were removed from mice and frozen at -80 °C in 
n-hexane for 30 minutes and kept at -80 °C until sectioning. They were embedded in Tissue-
Tek optimal cutting temperature (OCT) compound (Tissue-Tek, Miles Inc., Torrance, 
CA) and mounted on a cutting block. After freezing in a Reichert Frigocut microtome, 
the tissue was cut at 3-4 μm thickness and sections were picked up on Superfrost Plus 
microscope slides (Matsunami Glass Ind., LTD., Japan). For immunostaining, sections 
were incubated overnight at 4 °C in rabbit anti-rat AQP9 primary antibody. Slides were 
washed twice for 5 minutes in high-salt PBS (2.7% [w/v] NaCl) to reduce nonspecifi c 
staining (ELKJAER et al., 2000; MARÍA et al., 2005), and once in normal PBS. They were 
then incubated for 1 hour at room temperature with secondary antibody, a goat anti-rabbit 
IgG coupled to fl uorescein isothiocyanate (FITC). After being washed (PBS for 3 × 5 
min), sections were coverslipped, mounted in Vectashield (Vector Labs, Burlingame, CA) 
and examined under a Zeiss LSM 510 confocal fl uorescence microscope.
RNA isolation. Total cellular RNA was also isolated from the same tissues previously 
used for IHC by a modifi ed acid guanidinium thiocyanate phenol-chloroform extraction 
method (Trizol, GIBCO BRL, Life Technologies, Rockville, MD). Total RNA concentration 
was quantifi ed by spectrophotometry, and its quality (purity) was checked by electrophoresis 
in agarose gels (CHOMCZYNSKI and SACCHI, 2006). 
Reverse Transcription - Polymerase chain Reaction (RT-PCR). For detection of 
AQP9 mRNA, reverse transcription was performed using total RNA (5 μg); previously 
treated with DNase I buffer and DNase I amplifi cation grade for 15 minutes at 25 °C; 
and SuperScript II reverse transcriptase enzymes. Reverse transcription was achieved by 
heating the reaction mixture for 1 hour at 42 °C and then for 5 minutes at 95 °C, then 
chilling it on ice for 5 minutes to stop the reaction. The PCR experiment was performed 
using 1 μL of the cDNA product (template) plus 4 μL of PCR mix containing 10 Х PCR 
buffer (0.5 μL), 2.5 mM dNTPs (0.4 μL), Milli Q. (1 μL), Taq polymerase (0.1 μL), and 
specifi c primers (1 pmol/μL), forward (1 μL) and reverse (1 μL). The PCR amplifi cation 
cycle using a PCR thermal cycler machine (TakaRa Co., Otsu, Shiga, Japan) was 35 PCR 
cycles, one PCR cycle consisted of initial denaturing at 95 °C - 5min, denaturing at 95 
°C - 1 min, annealing at 62 °C - 1 min and extension reaction at 72 °C - 1min. After 35 
cycles, fi nal products were extended for 5 min at 72 °C. AQP9 amplifi ed cDNA fragments 
were resolved in 1.5% agarose gel containing ethidium bromide, and their electrophoretic 
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migration was compared against a 1 kp plus DNA ladder (Marker) and the products were 
photographed under ultraviolet illumination.
Electron microscopy (EM). For transmission EM, the livers of wild type and knockout 
mice were removed and fi xed in 2.5% glutaraldehyde at 4 °C overnight. They were then 
osmicated and embedded in Epon 812. Seventy-nm thick sections were cut on a Reichert-
E ultramicrotome and collected on formvar-coated EM grids. The ultrathin sections were 
stained in 5% uranyl acetate for 3 minutes, then in lead citrate for 1 minute, dried and 
fi nally examined using the electron microscope (Philips CM 400).
Statistical analysis. Data reported as the mean ± SE, were computer analyzed using 
SPSS 8.0 software (Statistical Package for the Social Sciences Inc, Chicago, Illinois, USA). 
Statistical comparisons between investigated groups were accomplished by unpaired t test 
(equal variances). P < 0.05 was considered statistically signifi cant.
Results
AQP9 knockout mice were generated as shown in Fig. 1. Under physiological 
conditions, knockout mice have normal embryonic survival, fertility, appearance, behavior, 
and plasma parameters, except for a signifi cant change in the level of some biochemical 
parameters.
Fig. 1. Genomic structure of mouse AQP9 DNA and knockout construct. The exon 5 was 
completely removed and substituted by a nucleotides sequence encoding a neomycin 
phosphotransferase expression cassette. 
Expression of AQP9 protein in mouse organs. Immunohistochemistry staining was 
used to localize AQP9 in different tissues of mice, males, females, wild, and/or KO-type. 
In wild mice, using rabbit anti-rat AQP9 antibodies, only the liver, epididymis and kidney 
(not previously identifi ed expression site) showed strong immunostaining, whereas there 
was a complete absence of staining in AQP9-/- mice. At high concentration, the AQP9 
antibody also stained different structures in the spleen and pancreas (not shown). 
Immunocytochemical localization of AQP9 in mice liver. Liver AQP9 expression was 
analyzed to determine cell distribution and membrane localization and whether AQP9 
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expression/distribution was dependent on sex and the knockout effect. AQP9+/+ male mice 
showed a more homogeneous hepatocyte staining by AQP9 (Fig. 2, A, C), whereas in 
female livers, the expression of AQP9 was mostly confi ned to perivascular hepatocytes 
(Fig. 2, B, D). Staining was restricted to the sinusoidal surfaces of hepatocyte plates of 
the liver. In some cases, there was little intracellular labeling. In AQP9-/- mice, there was 
no staining of the liver (Fig. 2, E, F). 
Immunofl uorescence. Immunofl uorescence staining of the liver was used to confi rm 
the subcellular localization and distribution of AQP9 in hepatocytes. Affi nity-purifi ed 
antibodies were used to stain cryostat liver sections from mice (Fig. 3). AQP9 was 
only found expressed in the hepatocytes of control mice (AQP9+/+ ). In male mice, the 
expression of AQP9 was found to be more homogeneous and involved all the hepatocytes 
(Fig. 3, A). However, in female mice, the expression was strongest in the cells closest 
to the central vein (Fig. 3, B). At higher magnifi cation, the staining was localized in the 
basolateral membrane of the cells in both male and female mice, whereas the apical bile 
canalicular membrane was not labeled (Fig. 3, C). The staining was completely absent in 
the AQP9-/- mouse (Fig. 3, D). 
Immunocytochemical localization of AQP9 in mice kidney. Immunoperoxidase labeling 
of kidney sections showing anti-AQP9 labeling in the distal and collecting tubules of 
AQP9+/+  mice of both sexes (a previously unidentifi ed expression site). In addition, very 
weak labeling was observed in the proximal tubules, whereas other nephron segments 
and glomeruli did not exhibit labeling in excess of background. In the distal tubule, the 
labeling was confi ned to cytoplasmic domains (in the apical, central, and basal parts of 
the cells) (Fig. 4, A, B) and the absence of, or very weak, labeling of basolateral plasma 
membrane domains. Similarly, in collecting duct cells, strong labeling was associated 
with intracellular structures (arrow in Fig. 4, B, C). The AQP9-/- mice of both sexes showed 
a complete absence of AQP9 staining in the kidney tissues (Fig. 4, E, F).
Immunohistochemical localization of AQP9 in the spleen. The AQP9+/+  mice, males 
and females showed AQP9 immunolabeling in the cells of white pulp (Fig. 5, A, B), 
whereas there was no labeling of cells in the red pulp. 
Immunohistochemical localization of AQP9 in reproductive organs. The testis, 
seminiferous epithelium, uterus and ovary of AQP+/+ mice showed no AQP9 expression, 
whereas there was only expression of anti-AQP9 labeling in the epididymis of male mice. 
In the epididymis, AQP9 was uniformly distributed over the microvilli of the principal 
cells of all regions, with the most intense reaction being noted in the initial segment and 
cauda regions. Intense labeling of the apical stereocilia was observed in the principal cells 
of the initial (Fig. 6, A, B) and distal (Fig. 6, C) segments of the epididymis. This staining 
was completely absent in AQP9-/- mice (Fig. 6, D). 
99Vet. arhiv 80 (1), 93-112, 2010
M. A. Hashem: Aquaporin 9 in wild and AQP9 knockout mice
Electron microscopy. Transmission electron microscopy showed no apparent 
differences in the structures of the liver in wild-type (Fig. 7, A) and AQP9 null (Fig. 7, B) 
mice. However, the bile canaliculi in KO-mice were shorter than in the wild-type.
RT-PCR analysis of the expression of AQP9 in mouse organs. For AQP9 genotyping, 
the mice were tested for the presence of disrupted AQP9 allele by PCR using genomic 
tail DNA and 2 primers. The 2 primers set produced the correct wild-type 605-bp-PCR 
product in the AQP9+/+ , while in the AQP9-/- mice it produced 350-bp-PCR product. 
Heterogeneous-type mice (AQP9+/-) have both PCR product sizes (Fig. 8). We examined 
the expression of AQP9 in a range of mice organs using mRNA encoding AQP9 of these 
tissues and AQP9-specifi c primer set. A house- keeping gene, GAPDH, was used as a 
positive control (Fig. 9, A, B, C, D). In AQP9+/+ mice of both sexes, all organs showed 
AQP9 expression by RT-PCR, except the pancreas, stomach, intestine and ovary (Fig. 
9, E, F). The tissues already reported containing AQP9 in wild-type mice were found as 
amplifi ed bands at the expected 437-bp position. AQP9-/- mice showed small PCR product 
size at 220 bp (Fig. 9, G, H).
Biochemical analysis. To examine whether AQP9-/- mice exhibit defects in the 
metabolism of various solutes, the concentrations of glycerol, triglycerides, total 
cholesterol, glucose, urea, alanine aminotransferase (ALT) and alkaline phosphatase 
(ALP) in serum samples from AQP9+/+ and AQP9-/- mice were determined (shown in Table 
1). AQP9-/- mice exhibited a marked increase in serum glycerol and triglyceride levels 
with a decrease in serum glucose (only after fasting) compared with AQP9+/+ mice. There 
were no signifi cant differences in the other measured parameters. Moreover, there were no 
statistical changes between male and female, wild and/or KO-type mice.
Table1. Serum values for some biochemical analyses in AQP9+/+  and AQP9-/-  mice 
Parameter Wild-type mice (AQP9+/+ ) KO-type mice (AQP9-/- ) 
male (n = 5) female (n = 5) male (n = 5) female (n = 5) 
Glycerol (μmol/L) 322.00 ± 18.95 319.55 ± 19.00 479.88* ±22.50 481.00* ± 24.14 
Triglycerides (mmol/L) 75.00 ± 4.00 80.55 ± 6.13 98.77* ± 7.40 110.00 * ± 6.95 
Total cholesterol (mmol/L) 180 .00 ± 8.10 174.18 ± 9.00 199.00 ± 11.54 187.55 ± 9.75 
Glucose 
(mmol/L) 
Random 120 .0 ± 4.88 118.00 ± 5.11 117.55 ± 4.16 118.22 ± 3.75 
9 hs after fasting 115 .00 ± 4.13 113 .00 ± 4.00 80.00* ± 3.50 85.00* ± 4.05 
Urea (mmol/L) 76.42 ± 4.19 73.00 ± 4.50 77.00 ± 3.00 75.22 ± 3.55 
ALT (U/L) 85.42 ± 5.22 84.00 ± 4.05 87.66 ± 4.14 85.53 ±.17 
ALP (U/L) 144.33 ± 8.11 145.00 ± 10.00 142.00 ± 9.34 141.00 ± 8.50 
Values are means ± SE; n = number of mice; *P<0.05; A-/- QP compared with the control (AQP+/+ ). 
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Fig. 2. Immunohistochemistry for AQP9 in liver of AQP9+/+ and AQP9-/- mice stained with rabbit 
polyclonal antibody at dilution 1:100. In male’s liver (A), immunoreactivity of AQP9 (brown 
staining) was more homogenous and widely distributed in hepatocytes than female’s liver (B) in 
which staining was mostly confi ned to perivascular hepatocytes. Higher magnifi cation showed 
staining of the sinusoidal plates (arrow heads) surrounding the central vein (CV) in the AQP9+/+ 
male (C) and female mice (D). The label appears to be more uniformly distributed in all the 
hepatocytes of male mice. However, AQP9-/- mice showed completely absent of AQP9 labeling in 
the liver (E, F). Original magnifi cations: A, B, E ×100; C, D, F ×200.
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Fig. 3. Immunofl uorescence localization of AQP9 in mice liver using anti-AQP9 antibodies. 
Frozen sections from liver of male (A) and female (B) wild-type mice (AQP9+/+ ) showing 
hepatocytes close to the central vein (CV) intensely labeled. The label appears to be more 
uniformly distributed in all the hepatocytes in male mice. (C) High magnifi cation showing the 
basolateral membrane expression of AQP9 (red arrows). A white arrow indicates the apical 
membrane of two hepatocytes. (D) AQP9-/- mice showed completely absence of labeling. Original 
magnifi cations: A, B, D ×200; C×400.
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Fig. 4. Immunocytochemistry localization of AQP9 in kidney using anti-AQP9 antibodies. 
AQP9+/+  mice showing anti-AQP9 labeling in the distal (A, B) and collecting (C, D) tubules. The 
labeling is mainly intracellular (arrows). E and F: immunolabeling AQP9-/- mice showing absence 
of AQP9 staining in all kidney tubules. Original magnifi cations: A, C, E ×200; B, D, F ×400.
103
M. A. Hashem: Aquaporin 9 in wild and AQP9 knockout mice
Vet. arhiv 80 (1), 93-112, 2010
Fig. 5. Immunocytochemistry localization of AQP9 in spleen using anti-AQP9 antibodies. 
A and B: AQP9+/+  mice showing anti-AQP9 labeling in the white pulp (WP). The labeling is 
mainly in the leukocytes (arrows). C and D: AQP9-/- mice showing complete absence of AQP9 
immunoreactivity. Original magnifi cations: A, C ×200; B, D ×400. 
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 Fig. 6. Immunohistochemistry localization of AQP9 staining in the epididymis. In AQP9+/+ mice 
(A C), AQP9 staining is concentrated at the apical pole (microvilli) of principal cells of initial 
segment (A, B). In cauda epididymidis (C), intense reaction is seen over the microvilli (thin 
arrows) of principal cells and cytoplasm of clear cells (thick arrows). Sperms in the lumen are 
unreactive. The staining is completely absent in the AQP9-/- mouse (D). Original magnifi cations: A 
×200; B, C, D ×400.
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Fig. 8. AQP9 genotyping. A 2Primers set were produced the correct PCR product at 605-bp for 
the wild-type (W) and at 350-bp for the knockout-type mice (K), while heterozygous-type mice 
have both PCR product size positions (H). 
Fig. 7. Electron microscopy examination of liver in AQP+/+ and AQP-/- mice. AQP-/- mice (B) 
showed short and small bile canaliculi (BC) comparatively with the AQP+/+ control mice (A). 
106
M. A. Hashem: Aquaporin 9 in wild and AQP9 knockout mice
Vet. arhiv 80 (1), 93-112, 2010
Fig. 9. AQP9 transcript analysis by RT-PCR of RNA isolated from different organs of mice. A 
house keeping gene, GAPDH, was used as a control positive with PCR product at 239-bp for male 
(A) and female; (B) wild-type mice and for KO-mice respectively (C&D). Primer pair “sense” 
and “antisense” produced the correct wild-type 437-bp-long product in the AQP9+/+ for male (E) 
and female (F) mice which is absent in the AQP9-/- mice. However, in AQP9-/- male (G) and female 
(H) mice, these primers amplifi ed 220-bp long PCR product, because whole exon5 containing 
the neo expression cassette is lost. Lane1-liver, 2- kidney, 3-spleen, 4-pancreas, 5-stomach, 6-
intestine, 7-testis or uterus, 8-epididymis or ovary, 9-heart, 10-lung, 11-skin, 12-brain. 
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Discussion
The goal of this study was to identify the main expression sites of AQP9 in wild and 
AQP9 knockout mice of both sexes and to determine whether knockout for AQP9 plays a 
role or affects the biochemical analyses in mice that thus far have remained undefi ned. 
Our data determined that AQP9 is more highly expressed in the liver, which represents 
its main expression site, than in the epididymis, kidney and spleen. The major fi nding 
reported here relates to the expression and subcellular localization of AQP9. Our results 
demonstrated that AQP9 expression is confi ned to the hepatocyte basolateral membrane, 
the plasma membrane facing the sinusoids. This pattern of staining may be consistent with 
CAPERNA et al. (2007), CARBREY et al. (2003), ELKJAER et al. (2000), KURIYAMA et al. 
(2002), MARINELLI et al. (2004), ROJEK et al. (2007). A new and interesting fi nding in the 
present study is the different expression observed between male and female AQP9+/+ mice. 
In the livers of female mice, the immunohistochemistry (IHC) signal was progressively 
more intense in hepatocytes close to the central vein (perivenous hepatocytes), whereas 
in the livers of male mice, the label appeared to be more uniformly distributed in all the 
hepatocytes. This indicates that differences in the liver may be gender-dependent (PASTOR-
SOLER et al., 2002). Moreover, our immunofl uorescence signal confi rmed the basolateral 
localization of AQP9 with IHC results and this is in agreement with HUEBERT et al. (2002). 
It is well established that many hepatic functions are expressed in a sexually dimorphic 
fashion (NICCHIA et al., 2001). A number of hepatic enzymes, plasma membrane receptors 
and transcription factors have been shown to be sexually dimorphic (SIMON et al., 1996). 
In contrast, AQP9-/- mice did not show any immunostaining. A recently identifi ed member 
of the AQP family, AQP9, was expressed specifi cally in the distal and collecting tubules 
of the kidneys. This indicates a key role of AQP9 function in the kidney as a water channel 
protein. Moreover, the principal renal cells in some parts of the collecting duct have high 
levels of both AQP3 and AQP4 on their basolateral plasma membranes (ISHIBASHI et 
al., 1997). In this case also, one of the expressed channels (AQP4) is conductive only 
to water, while the others (AQP3, AQP9) are promiscuous water channels with high 
urea and glycerol permeability. At high concentration, the AQP9 antibody also stained 
different structures in the spleen and pancreas, but these results may be attributed to 
non specifi c binding of the antibody, especially for the pancreas, which showed no 
band correspondence to a specifi c AQP9 fragment with RT- PCR. Our results were in 
coincidence with ELKJAER et al. (2000) and ISHIBASHI et al. (1998). 
Concerning IHC for the male reproductive tract, AQP9 is abundantly expressed 
in different segments of AQP9+/+ mice, where it could represent an apical pathway for 
transepithelial water fl ow. In the epididymis, AQP9 was localized on the microvilli of 
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the principal cells of all regions (ELKJAER et al., 2000; HUANG et al., 2006; PASTOR-
SOLER et al., 2002; RUZ et al., 2006). However, in the present study, AQP9 expression 
on the microvilli of the principal cells was noted to be region-specifi c, with the most 
intense reaction being noted in the initial segment and cauda regions. Similar results were 
obtained by BADRAN and HERMO (2002). Therefore, in the proximal portion, AQP9 is the 
only AQP so far detected on principal cells, whereas in the distal portion it is coexpressed 
with AQP2 on principal cell apical membranes (PASTOR-SOLER et al., 2001). The testes 
did not show any AQP9 labeling, although other authors have observed it. The difference 
may be due to the use of single anti-AQP9 antibody in this study and/or probably because 
its expression level from AQP9 is very low. These results are consistent with localization 
of AQP9 in the testis by weak intensity than in the epididymis, which revealed strong 
PCR product band as shown by RT-PCR. Our data now show that AQP9 is an abundant 
apical membrane protein in mice epididymis and other regions of the reproductive tract; 
it appears to be a constitutive apical membrane protein that may be responsible for apical 
membrane water and/or solute permeability of these epithelia. In female wild-type mice, 
AQP9, which had not been identifi ed by IHC analysis, probably because its expression 
level was low, was found to be present in the uterus as shown by RT-PCR. 
Using RT-PCR, we showed that most tissues of wild-type mice expressed AQP9-
PCR product at 437bp position. However, a smaller 220-bp product was amplifi ed from 
cDNA from KO-mice because the whole exon5 containing the neoexpression cassette was 
lost. In KO-mice, DNA sequencing showed that the smaller product is an alternatively 
spliced transcript, where exon4 is spliced directly to exon6. Our data were in harmony 
with CAPERNA et al. (2007). 
With regard to the biochemical study, serum levels of glycerol and triglycerides were 
markedly increased, in association with hypoglycemia in AQP9-/- mice, revealing a role of 
AQP9 in glycerol metabolism. Aquaporin subtypes 7 and 9 have vital roles in the control of 
glycerol channels in adipocytes and hepatocytes, and thereby the balance between glycerol 
release and uptake by adipocytes and the liver, respectively (MAEDA et al., 2008). Glycerol, a 
product of adipose tissue lipolysis, is an important substrate for hepatic gluconeogenesis. As 
the substrate for hepatic glucose production, glycerol accounts for 90% in the prolonged fasting 
state and 50% in the postabsorptive state in rodents (KURIYAMA et al., 2002). Its abundant 
expression in the liver of normal mice strongly suggests that the increased serum glycerol 
levels in AQP9-/- mice are caused by an absence of hepatic AQP9 and an impaired uptake of 
glycerol through the hepatocyte plasma membrane. Although the increased serum glycerol 
level in AQP9 null mice is likely to be mediated by absence of AQP9, it cannot be excluded 
that the uptake and release of glycerol by other organs expressing aquaglyceroporins, e.g., 
kidney cortex (AQP3 and AQP7), fat tissue (AQP7), or intestine (AQP3 and AQP10), may 
also infl uence the fi nal plasma glycerol level (ROJEK et al., 2007). Interestingly, according 
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to the model of metabolic zonation of the liver, gluconeogenesis takes place predominantly 
in the hepatocytes surrounding the portal vein (periportal) that express little AQP9, whereas 
relatively less gluconeogenesis takes place in the hepatocytes surrounding the central vein 
(perivenous), where highest AQP9 levels are detected (JUNGERMANN and KIETZMANN, 
1997). Thus, it cannot be excluded that AQP9 may have additional functions in mouse 
liver other than glycerol transport. The hypoglycemia in our results suggesting that the 
absence of AQP9 in the hepatocyte membrane reduced the capacity for glycerol entrance 
for gluconeogenesis, leading to reduced serum glucose levels specially during fasting of 
AQP-null mice (CARBREY et al., 2003; KURIYAMA et al., 2002; ROJEK et al., 2007).Therefore, 
our studies of AQP9 protein strongly support the role for AQP9 expression in the liver as 
a molecular mechanism for maximizing glycerol infl ux during states requiring increased 
gluconeogenesis. 
Our data concluded that AQP9 is a major water channel protein that is expressed throughout 
different organs, with high expression in the liver of male mice. In this study the kidney was 
shown to be a newly identifi ed AQP9 expression site a. Hence, this recent identifi cation of 
intracellular AQP will open new areas of research into cell biology and expand the scope of 
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divljih miševa i miševa s odstranjenim genom za AQP9. Vet. arhiv 80, 93-112, 2010.
SAŽETAK
Svrha ovog istraživanja bila je odrediti stanični i supstanični nalaz akvaporina AQP9 u različitim organima 
miševa divljeg tipa (AQP9+/+) i miševa s odstranjenim genom za AQP9 (AQP9–/–) imunohistokemijski, 
imunofl urescencijom i RT-PCR-om kao i biokemijskim pretragama. Upotrijebljeno je dvadeset miševa divljeg 
tipa i homozigotnih AQP9 „knockout“ miševa (C57 BL/6J). I jedna AQP9+/+ i druga AQP9–/– skupina miševa 
bile su nasumce podijeljene u četiri podskupine na osnovi spola. Imunohistokemijske pretrage pokazale su da se 
specifi čno obilježen AQP9 nalazi u hepatocitima, bubregu, slezeni i epididimisu miševa divljeg tipa (AQP9+/+), 
a da ga nema u miševa AQP9–/–. U jetri je imunohistokemijska reakcija bila najjača u sinusoidnoj površini, a 
slaba intracelularno. Ustanovljeno je da je ekspresija AQP9 vezana uz spol. U jetri ženki ekspresija AQP9 bila 
je pretežito ograničena na perivaskularne hepatocite, dok je u mužjaka obojenost hepatocita bila homogena. 
Konfokalnom imunofl uorescencijom potvrđena je lokalizacija AQP9 na bazolateralnoj plazminoj membrani 
hepatocita. U usporedbi s kontrolnim miševima serumske razine glicerola i triglicerida bile su značajno 
(P<0,05) povišene u pokusnih miševa te povezane s hipoglikemijom u miševa AQP9–/–, dok vrijednosti za 
ukupni kolesterol, ureju, alanin aminotransferazu i alkalnu fosfatazu nisu bile statistički promijenjene. 
Ključne riječi: akvaporin 9, miševi s odstranjenim genom, imunohistokemija, serumski glicerol
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